783 related articles for article (PubMed ID: 21797106)
1. Serum inflammatory cytokines IL-1beta, IL-6, TNF-alpha and VEGF have influence on the development of diabetic retinopathy.
Koleva-Georgieva DN; Sivkova NP; Terzieva D
Folia Med (Plovdiv); 2011; 53(2):44-50. PubMed ID: 21797106
[TBL] [Abstract][Full Text] [Related]
2. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
[TBL] [Abstract][Full Text] [Related]
3. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of SOCS6 are decreased in diabetic retinopathy and are related to severity of the disease.
Li L; Wu X; He L; Luo R; Lou L
Adv Clin Exp Med; 2023 Aug; 32(8):873-880. PubMed ID: 37589228
[TBL] [Abstract][Full Text] [Related]
5. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
Zhu H; Shi CH
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
[TBL] [Abstract][Full Text] [Related]
6. Cytokine profile of peripheral blood in type 2 diabetes mellitus patients with diabetic retinopathy.
Lee JH; Lee W; Kwon OH; Kim JH; Kwon OW; Kim KH; Lim JB
Ann Clin Lab Sci; 2008; 38(4):361-7. PubMed ID: 18988929
[TBL] [Abstract][Full Text] [Related]
7. The role of vascular endothelial growth factor, tumor necrosis factor alpha and interleukin-6 in pathogenesis of diabetic retinopathy.
Myśliwiec M; Balcerska A; Zorena K; Myśliwska J; Lipowski P; Raczyńska K
Diabetes Res Clin Pract; 2008 Jan; 79(1):141-6. PubMed ID: 17716775
[TBL] [Abstract][Full Text] [Related]
8. The effects of Bushen Yiqi Huoxue prescription and its disassembled prescriptions on a diabetic retinopathy model in Sprague Dawley rats.
Xie M; Deng L; Yu Y; Xie X; Zhang M
Biomed Pharmacother; 2021 Jan; 133():110920. PubMed ID: 33232926
[TBL] [Abstract][Full Text] [Related]
9. Multiplex bead array assay of plasma cytokines in type 2 diabetes mellitus with diabetic retinopathy.
Hang H; Yuan S; Yang Q; Yuan D; Liu Q
Mol Vis; 2014; 20():1137-45. PubMed ID: 25253986
[TBL] [Abstract][Full Text] [Related]
10. [The assessment of the correlation between vascular endothelial growth factor (VEGF), tumor necrosis factor (TNF-alpha), interleukin 6 (IL-6), glycaemic control (HbA1c) and the development of the diabetic retinopathy in children with diabetes mellitus type 1].
Myśliwiec M; Balcerska A; Zorena K; Myśliwska J; Lipowski P; Raczyńska K
Klin Oczna; 2007; 109(4-6):150-4. PubMed ID: 17725274
[TBL] [Abstract][Full Text] [Related]
11. TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.
Gustavsson C; Agardh E; Bengtsson B; Agardh CD
J Diabetes Complications; 2008; 22(5):309-16. PubMed ID: 18413212
[TBL] [Abstract][Full Text] [Related]
12. Low blood and vitreal BDNF, LXA4 and altered Th1/Th2 cytokine balance are potential risk factors for diabetic retinopathy.
Kaviarasan K; Jithu M; Arif Mulla M; Sharma T; Sivasankar S; Das UN; Angayarkanni N
Metabolism; 2015 Sep; 64(9):958-66. PubMed ID: 26004392
[TBL] [Abstract][Full Text] [Related]
13. Concentrations of Selected Cytokines and Vascular Endothelial Growth Factor in Aqueous Humor and Serum of Diabetic Patients.
Cvitkovic K; Sesar A; Sesar I; Pusic-Sesar A; Pejic R; Kelava T; Sucur A; Cavar I
Semin Ophthalmol; 2020 Feb; 35(2):126-133. PubMed ID: 32310727
[No Abstract] [Full Text] [Related]
14. Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients.
Ju HB; Zhang FX; Wang S; Song J; Cui T; Li LF; Zhang HY
Medicine (Baltimore); 2017 Aug; 96(31):e7671. PubMed ID: 28767589
[TBL] [Abstract][Full Text] [Related]
15. [Pro-inflammatory serum cytokines in diabetic retinopathy].
Hernández-Da Mota SE; Soto-Bahena JJ; Viveros-Sandoval ME; Cardiel-Ríos M
Cir Cir; 2015; 83(2):100-6. PubMed ID: 25986974
[TBL] [Abstract][Full Text] [Related]
16. Expression of T-helper-associated cytokines in patients with type 2 diabetes mellitus with retinopathy.
Chen H; Wen F; Zhang X; Su SB
Mol Vis; 2012; 18():219-26. PubMed ID: 22312190
[TBL] [Abstract][Full Text] [Related]
17. Correlation of various serum biomarkers with the severity of diabetic retinopathy.
Nalini M; Raghavulu BV; Annapurna A; Avinash P; Chandi V; Swathi N; Wasim
Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S451-S454. PubMed ID: 28420575
[TBL] [Abstract][Full Text] [Related]
18. Aqueous Humor Cytokines in Non-Proliferative Diabetic Retinopathy.
Obadă O; Pantalon AD; Rusu-Zota G; Hăisan A; Lupuşoru SI; Constantinescu D; Chiseliţă D
Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888628
[TBL] [Abstract][Full Text] [Related]
19. Changes in TL1A levels and associated cytokines during pathogenesis of diabetic retinopathy.
Zhang ZH; Chen QZ; Jiang F; Townsend TA; Mao CJ; You CY; Yang WH; Sun ZY; Yu JG; Yan H
Mol Med Rep; 2017 Feb; 15(2):573-580. PubMed ID: 28000874
[TBL] [Abstract][Full Text] [Related]
20. Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness.
Ozturk BT; Bozkurt B; Kerimoglu H; Okka M; Kamis U; Gunduz K
Mol Vis; 2009 Sep; 15():1906-14. PubMed ID: 19784389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
